9.000
+1,12%
2026-10-19
Fundamental Analysis
31 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -48.9% | -42.6% | 0 / 3 | -54.9% | +9.26 pp | +0.12 pp | +1.9% | 0.84 | 43.24 | 282 | −54,9% | 2,9 | −48,9% | 43.24 | 38.57 | +12,1% |
| Pts | 0 | 0 | 0 | 0 | 12 | 8 | 0 | 6 | 8 | |||||||
Valuation annotation:Price: 9.000 (close price on 2026-10-19)EPS (TTM): 208,2
Financial charts
1.Revenue & growth
VND bn282Q2/26
1.Revenue & growth
VND bn282Q2/26
2.Profit & growth
VND bn2,89Q2/26
3.Profit mix (Penman)
VND bn28,3Q2/26
4.Margins & cost structure
%11.8%Q2/26
5.Returns & cash cycle
% · days3.7%Q2/26
6.Earnings quality & cash
VND bn207Q2/26
7.Asset structure
VND bn3.894Q2/26
8.Funding & debt health
VND bn · times3.894Q2/26
9.Revenue backlog
VND bn521Q2/26
10.Valuation
times · %43,2×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %28Q2/26
Adjusted EPS growth, latest quarter
-48.9%
Average adjusted EPS growth, 3 quarters
-30.7%
averaged over 2 quarter(s)
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26